Literature DB >> 16479112

Clinicopathologic characteristics of hepatitis C virus-associated intrahepatic cholangiocarcinoma.

Seikan Hai1, Shoji Kubo, Satoshi Yamamoto, Takahiro Uenishi, Hiromu Tanaka, Taichi Shuto, Shigekazu Takemura, Osamu Yamazaki, Kazuhiro Hirohashi.   

Abstract

BACKGROUND: Although hepatitis C virus (HCV) infection is a possible pathogenetic factor for intrahepatic cholangiocarcinoma (ICC), clinicopathologic features of ICC patients with HCV infection remain unclear. PATIENTS AND METHODS: Of 50 patients with ICC treated, 19 were infected with HCV (HCV-positive group) and 38 underwent surgical treatment. Clinicopathologic features and postoperative outcome were compared between patients with and without HCV infection.
RESULTS: In 15 patients in the HCV-positive group, ICC was detected during follow-up for chronic hepatitis C. The proportion of patients who underwent curative resection was significantly higher in the HCV-positive than in the HCV-negative group, and tumors were significantly smaller in the HCV-positive than in the HCV-negative group. In the HCV-positive group, tumors were significantly smaller in patients who were followed up for chronic hepatitis C than in patients who were not followed up. Although cumulative survival rates did not differ significantly between groups, prognoses of patients with small ICC were significantly better than those with large ICC.
CONCLUSION: Follow-up for patients with chronic hepatitis C by imaging series at regular intervals is important and provides the possibility to detect a small ICC as well as a hepatocellular carcinoma. Resection should be guided by liver function and the tumor stage in patients with HCV-associated ICC. Copyright (c) 2005 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2006        PMID: 16479112     DOI: 10.1159/000091446

Source DB:  PubMed          Journal:  Dig Surg        ISSN: 0253-4886            Impact factor:   2.588


  8 in total

Review 1.  Surgical treatment for intrahepatic cholangiocarcinoma.

Authors:  Takahiro Uenishi; Takatsugu Yamamoto; Shigekazu Takemura; Shoji Kubo
Journal:  Clin J Gastroenterol       Date:  2014-02-15

2.  A case of intrahepatic cholangiocarcinoma detected after successful interferon therapy for chronic hepatitis C.

Authors:  Hiroji Shinkawa; Seikan Hai; Hiromu Tanaka; Shigekazu Takemura; Kazuki Ohba; Takahiro Uenishi; Shintaro Kodai; Yorihisa Urata; Kazuhisa Kaneda; Masayuki Sakae; Kenichi Wakasa; Shoji Kubo
Journal:  Clin J Gastroenterol       Date:  2009-12-03

Review 3.  Intrahepatic cholangiocarcinoma and cholangiolocellular carcinoma in cirrhosis and chronic viral hepatitis.

Authors:  Shun-ichi Ariizumi; Masakazu Yamamoto
Journal:  Surg Today       Date:  2014-09-25       Impact factor: 2.549

4.  Low Incidence of Lymph Node Metastasis After Resection of Hepatitis Virus-Related Intrahepatic Cholangiocarcinoma.

Authors:  Hiroya Iida; Masaki Kaibori; Shogo Tanaka; Shigekazu Takemura; Hiroshi Wada; Fumitoshi Hirokawa; Takuya Nakai; Michihiro Hayashi; Hidetoshi Eguchi; Shoji Kubo
Journal:  World J Surg       Date:  2017-04       Impact factor: 3.352

5.  Prognosis after resection for hepatitis B virus-associated intrahepatic cholangiocarcinoma.

Authors:  Zhen-Feng Wu; Xiao-Yu Wu; Nan Zhu; Zhe Xu; Wei-Su Li; Hai-Bin Zhang; Ning Yang; Xue-Quan Yao; Fu-Kun Liu; Guang-Shun Yang
Journal:  World J Gastroenterol       Date:  2015-01-21       Impact factor: 5.742

Review 6.  Hepatitis B virus and hepatitis C virus play different prognostic roles in intrahepatic cholangiocarcinoma: A meta-analysis.

Authors:  Zheng Wang; Yuan-Yuan Sheng; Qiong-Zhu Dong; Lun-Xiu Qin
Journal:  World J Gastroenterol       Date:  2016-03-14       Impact factor: 5.742

Review 7.  Possible association between hepatitis C virus and malignancies different from hepatocellular carcinoma: A systematic review.

Authors:  Sirio Fiorino; Letizia Bacchi-Reggiani; Dario de Biase; Adele Fornelli; Michele Masetti; Andrea Tura; Fabio Grizzi; Matteo Zanello; Laura Mastrangelo; Raffaele Lombardi; Giorgia Acquaviva; Luca di Tommaso; Arrigo Bondi; Michela Visani; Sergio Sabbatani; Laura Pontoriero; Carlo Fabbri; Andrea Cuppini; Annalisa Pession; Elio Jovine
Journal:  World J Gastroenterol       Date:  2015-12-07       Impact factor: 5.742

8.  Combined hepatocellular cholangiocarcinomas; analysis of a large database.

Authors:  Mitchell S Wachtel; Yan Zhang; Tom Xu; Maurizio Chiriva-Internati; Eldo E Frezza
Journal:  Clin Med Pathol       Date:  2008-03-19
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.